Eu Ivdd Eu Ivd Annex 2 List B On The Market 🇹🇼 Taiwan

Spengler TB100

Tyson Bioresearch, Inc. · 🇹🇼 Taiwan
Devices (same UDI-DI)
1
Certificates
1
Countries
0
Notified Bodies
1

Basic Information

Primary DI
D-T05D5710003ANJ6
Basic UDI-DI Code
B-T05D5710003ANJ6
Reference
745010
Device Types
None provided
Regulation
Eu Ivdd
Classification
Eu Ivd Annex 2 List B
Status
On The Market

Additional Description

The Spengler TB100 Blood Glucose Monitoring System is intended for use in the quantitatively measurement of glucose (sugar) in fresh capillary whole blood from the fingertip and the alternative sites: the palm and the forearm. The Spengler TB100 Blood Glucose Test Strips are for testing outside the body (in vitro diagnostic use). The Spengler TB100 Blood Glucose Monitoring System is intended for use at home (over the counter [OTC]) by persons with diabetes, or in clinical setting by healthcare professionals as an aid in monitoring the effectiveness of diabetes control. It is not intended for the diagnosis of or screening for diabetes mellitus. The alternative site testing in the systems can be used only during steady-state blood glucose conditions.

CND Nomenclature Codes

Code Description
W0101060101 GLUCOSE TEST STRIPS

Certificates

Type Number
IVDD Annex IV (excluding sections 4, 6) C-02-1073-797-22

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd Annex 2 List B) and regulation (EU IVDD).

View all